RDFA
Ritter Daniher Financial Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $126K | Hold |
282
| – | – | 0.03% | 115 |
|
|
2025
Q1 | $137K | Sell |
282
-15
| -5% | -$7.27K | 0.04% | 103 |
|
|
2024
Q4 | $120K | Sell |
297
-29
| -9% | -$11.7K | 0.03% | 107 |
|
|
2024
Q3 | $152K | Hold |
326
| – | – | 0.04% | 95 |
|
|
2024
Q2 | $153K | Hold |
326
| – | – | 0.05% | 87 |
|
|
2024
Q1 | $136K | Sell |
326
-78
| -19% | -$32.6K | 0.05% | 99 |
|
|
2023
Q4 | $164K | Sell |
404
-46
| -10% | -$18.7K | 0.06% | 82 |
|
|
2023
Q3 | $156K | Buy |
450
+184
| +69% | +$64K | 0.07% | 78 |
|
|
2023
Q2 | $93.6K | Hold |
266
| – | – | 0.04% | 105 |
|
|
2023
Q1 | $83.8K | Hold |
266
| – | – | 0.04% | 107 |
|
|
2022
Q4 | $76.8K | Buy |
+266
| New | +$76.8K | 0.04% | 115 |
|